Hilda van den Bos

885 total citations
20 papers, 411 citations indexed

About

Hilda van den Bos is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Hilda van den Bos has authored 20 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Hilda van den Bos's work include Cancer Genomics and Diagnostics (12 papers), Genomic variations and chromosomal abnormalities (5 papers) and Single-cell and spatial transcriptomics (4 papers). Hilda van den Bos is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Genomic variations and chromosomal abnormalities (5 papers) and Single-cell and spatial transcriptomics (4 papers). Hilda van den Bos collaborates with scholars based in Netherlands, Sweden and Canada. Hilda van den Bos's co-authors include Floris Foijer, Peter M. Lansdorp, Diana C.J. Spierings, Björn Bakker, Maria Colomé‐Tatché, Victor Guryev, Aaron Taudt, Anke van den Berg, T. Jeroen N. Hiltermann and Harry J.M. Groen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hilda van den Bos

19 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilda van den Bos Netherlands 11 207 198 128 84 78 20 411
Marni B. Siegel United States 11 182 0.9× 156 0.8× 160 1.3× 30 0.4× 61 0.8× 16 410
Reniqua House United States 11 391 1.9× 157 0.8× 50 0.4× 78 0.9× 48 0.6× 11 520
Kathryn B. Grandinetti United States 10 400 1.9× 91 0.5× 115 0.9× 74 0.9× 37 0.5× 13 534
Helena Antoniadis Switzerland 7 235 1.1× 64 0.3× 128 1.0× 44 0.5× 63 0.8× 8 350
Haritha Mathsyaraja United States 10 373 1.8× 138 0.7× 131 1.0× 28 0.3× 31 0.4× 10 520
Sarah Bailey United States 10 585 2.8× 128 0.6× 146 1.1× 51 0.6× 130 1.7× 16 667
Mónica Fernández‐Cortés Spain 8 283 1.4× 152 0.8× 153 1.2× 33 0.4× 19 0.2× 9 408
Diana Hubbard United States 3 328 1.6× 123 0.6× 170 1.3× 48 0.6× 35 0.4× 6 457
Alberto L’Abbate Italy 8 332 1.6× 188 0.9× 59 0.5× 68 0.8× 79 1.0× 20 532
C-X Deng United States 9 413 2.0× 100 0.5× 262 2.0× 215 2.6× 83 1.1× 11 576

Countries citing papers authored by Hilda van den Bos

Since Specialization
Citations

This map shows the geographic impact of Hilda van den Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilda van den Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilda van den Bos more than expected).

Fields of papers citing papers by Hilda van den Bos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilda van den Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilda van den Bos. The network helps show where Hilda van den Bos may publish in the future.

Co-authorship network of co-authors of Hilda van den Bos

This figure shows the co-authorship network connecting the top 25 collaborators of Hilda van den Bos. A scholar is included among the top collaborators of Hilda van den Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilda van den Bos. Hilda van den Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Styring, Emelie, Linda Magnusson, Hilda van den Bos, et al.. (2024). CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma. npj Genomic Medicine. 9(1). 42–42. 4 indexed citations
3.
Kováč, Michal, Louise Cornmark, Linda Magnusson, et al.. (2023). Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway. The Journal of Pathology. 262(2). 147–160. 10 indexed citations
4.
Woodward, E. L., Minjun Yang, Hilda van den Bos, et al.. (2023). Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia. Nature Communications. 14(1). 1658–1658. 8 indexed citations
5.
Yu, Lei, Vincent W. Bloks, Hong Yang, et al.. (2023). Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia. SHILAP Revista de lepidopterología. 11(1). 5–5. 1 indexed citations
6.
Aaltonen, Kristina, Karin Hansson, Hilda van den Bos, et al.. (2022). Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance. Science Advances. 8(43). eabq4617–eabq4617. 20 indexed citations
7.
Tamminga, Menno, Kiki Andree, Hilda van den Bos, et al.. (2021). Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival. British Journal of Cancer. 126(3). 409–418. 9 indexed citations
8.
Schukken, Klaske M., Yu‐Chih Lin, Petra L. Bakker, et al.. (2020). Altering microtubule dynamics is synergistically toxic with spindle assembly checkpoint inhibition. Life Science Alliance. 3(2). e201900499–e201900499. 17 indexed citations
9.
Cornmark, Louise, Jakob Hofvander, Linda Magnusson, et al.. (2020). Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma. The Journal of Pathology Clinical Research. 6(4). 231–237. 11 indexed citations
10.
Sladky, Valentina C., Tamás Szabó, Laura Bongiovanni, et al.. (2020). PIDDosome‐induced p53‐dependent ploidy restriction facilitates hepatocarcinogenesis. EMBO Reports. 21(12). e50893–e50893. 28 indexed citations
11.
Tamminga, Menno, Kiki Andree, T. Jeroen N. Hiltermann, et al.. (2020). Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET. Cancers. 12(4). 896–896. 36 indexed citations
12.
Tamminga, Menno, Sanne de Wit, Caroline Van De Wauwer, et al.. (2019). Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer. Clinical Cancer Research. 26(7). 1656–1666. 29 indexed citations
13.
Tamminga, Menno, Kiki Andree, Hilda van den Bos, et al.. (2019). Diagnostic Leukapheresis Increases Circulating Tumor Cell Yield in Non-Small Cell Lung Cancer Patients, Which Correspond with Response and Survival. SSRN Electronic Journal. 1 indexed citations
14.
Bos, Hilda van den, Björn Bakker, Aaron Taudt, et al.. (2018). Quantification of Aneuploidy in Mammalian Systems. Methods in molecular biology. 1896. 159–190. 23 indexed citations
15.
Bos, Hilda van den, Björn Bakker, Diana C.J. Spierings, Peter M. Lansdorp, & Floris Foijer. (2017). Single-cell sequencing to quantify genomic integrity in cancer. The International Journal of Biochemistry & Cell Biology. 94. 146–150. 14 indexed citations
16.
Bos, Hilda van den. (2017). Aneuploidy in the human brain and cancer: Studying heterogeneity using single-cell sequencing. Data Archiving and Networked Services (DANS). 1 indexed citations
17.
Bos, Hilda van den, Diana C.J. Spierings, Aaron Taudt, et al.. (2016). Single-cell whole genome sequencing reveals no evidence for common aneuploidy in normal and Alzheimer’s disease neurons. Genome biology. 17(1). 116–116. 93 indexed citations
18.
Bakker, Björn, Hilda van den Bos, Peter M. Lansdorp, & Floris Foijer. (2015). How to count chromosomes in a cell: An overview of current and novel technologies. BioEssays. 37(5). 570–577. 42 indexed citations
19.
Bouma, Hjalmar R., Iryna Samarska, H Schenk, et al.. (2013). Microarray analysis of gene expression profiles in the rat kidney demonstrates a local inflammatory response induced by cardiopulmonary bypass. European Journal of Anaesthesiology. 30(8). 492–500. 5 indexed citations
20.
Smigielska‐Czepiel, Katarzyna, Anke van den Berg, Pytrick Jellema, et al.. (2013). Dual Role of miR-21 in CD4+ T-Cells: Activation-Induced miR-21 Supports Survival of Memory T-Cells and Regulates CCR7 Expression in Naive T-Cells. PLoS ONE. 8(10). e76217–e76217. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026